Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Cato M. H. de Vos, Natasha L. Mason, Kim P. C. Kuypers
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review
Kwonmok Ko, Gemma Knight, James Rucker, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 159
Synaptic plasticity and mental health: methods, challenges and opportunities
Lawrence G. Appelbaum, Mohammad Ali Shenasa, Louise A. Stolz, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 113-120
Open Access | Times Cited: 106
Must Psilocybin Always “Assist Psychotherapy”?
Guy M. Goodwin, Ekaterina Malievskaia, Gregory A. Fonzo, et al.
American Journal of Psychiatry (2023) Vol. 181, Iss. 1, pp. 20-25
Closed Access | Times Cited: 100
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis
Kwonmok Ko, Emma I Kopra, Anthony J. Cleare, et al.
Journal of Affective Disorders (2022) Vol. 322, pp. 194-204
Closed Access | Times Cited: 87
Therapeutic effect of psilocybin in addiction: A systematic review
Pim B. van der Meer, Juan José Fuentes, Ad A. Kaptein, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 74
Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
Mauro Cavarra, Alessandra Falzone, Johannes G. Ramaekers, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 71
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112203-112203
Open Access | Times Cited: 70
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
Laura Ley, Friederike Holze, Denis Arikci, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 11, pp. 1659-1667
Open Access | Times Cited: 70
Hydrophobic Deep Eutectic Solvents as Greener Substitutes for Conventional Extraction Media: Examples and Techniques
Madhusmita Devi, Rimjhim Moral, Sanjib Thakuria, et al.
ACS Omega (2023) Vol. 8, Iss. 11, pp. 9702-9728
Open Access | Times Cited: 63
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Psychedelic Medicine Exceptionalism
I. Glenn Cohen, Mason Marks
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 6-15
Open Access | Times Cited: 9
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials
Lavinia Hogea, Dana Cătălina Tabugan, Iuliana Costea, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 278-278
Open Access | Times Cited: 2
Psychedelics therapeutics: What we know, what we think, and what we need to research
David Nutt, Meg J. Spriggs, David Erritzøe
Neuropharmacology (2022) Vol. 223, pp. 109257-109257
Open Access | Times Cited: 64
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Devon Stoliker, Gary F. Egan, Karl Friston, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 876-917
Open Access | Times Cited: 56
Therapeutic use of psilocybin: Practical considerations for dosing and administration
Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 49
Psychedelics and Neural Plasticity: Therapeutic Implications
Steven F. Grieco, Eero Ċastrén, Gitte M. Knudsen, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 45, pp. 8439-8449
Open Access | Times Cited: 45
Sustained effects of single doses of classical psychedelics in humans
Gitte M. Knudsen
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 145-150
Open Access | Times Cited: 39
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Andrea Mastinu, Margrate Anyanwu, Marinella Carone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1329-1329
Open Access | Times Cited: 37
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain
Orr Shahar, Alexander Botvinnik, Amit Shwartz, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 7, pp. 2059-2073
Open Access | Times Cited: 15
Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways
Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102211-102211
Closed Access | Times Cited: 13
Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder
Brandon Weiss, Leor Roseman, Bruna Giribaldi, et al.
International Journal of Mental Health and Addiction (2024) Vol. 22, Iss. 2, pp. 806-841
Open Access | Times Cited: 13
Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder
Chloe E. Page, C. Neill Epperson, Andrew M. Novick, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 12, pp. 3802-3813
Closed Access | Times Cited: 12
An Integrated theory of false insights and beliefs under psychedelics
H. T. McGovern, Hilary Jane Grimmer, Manoj K. Doss, et al.
Communications Psychology (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 11
Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
Robin J. Murphy, Kate Godfrey, Alexander D. Shaw, et al.
BMC Neuroscience (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top